Vorinostat (Q56002311)

From Wikidata

Jump to navigation Jump to search

article from 2007

Language	Label	Description	Also known as
English	Vorinostat	article from 2007

Statements

scholarly article

0 references

Vorinostat (English)

0 references

Peter Kirkpatrick

3

object named as

Peter Kirkpatrick

0 references

author name string

Steven Grant

1

0 references

Chris Easley

2

0 references

publication date

January 2007

0 references

Nature Reviews Drug Discovery

0 references

6

0 references

1

0 references

21-22

0 references

Epigenetic therapy of cancer: past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Immunopathogenesis and therapy of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

31 March 2020

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

1 reference

https://api.crossref.org/works/10.1038%2FNRD2227

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NRD2227

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56002311&oldid=2212931142"